Analysis of changes in circular RNA expression and construction of ceRNA networks in human dilated cardiomyopathy

Zhenhao Lin1,2, Yongchao Zhao1,2, Fangjie Dai1,2

  • 1Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.

Insights

Circular RNAs (circRNAs) show altered expression in dilated cardiomyopathy (DCM) patients. This study identifies key circRNAs and constructs networks, offering new insights into DCM mechanisms.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Epigenetics

Background:

  • Dilated cardiomyopathy (DCM) is a severe, life-threatening heart condition with unclear underlying mechanisms.
  • Circular RNAs (circRNAs) are implicated in cardiovascular diseases, potentially acting as competitive endogenous RNAs (ceRNAs).
  • The specific role of circRNAs in human DCM remains largely unelucidated.

Purpose of the Study:

  • To identify differentially expressed circRNAs in human DCM.
  • To explore the potential functions of these circRNAs in DCM pathogenesis.
  • To construct circRNA-miRNA-mRNA networks based on ceRNA theory.

Main Methods:

  • RNA sequencing of heart samples from DCM patients and healthy controls.
  • Validation of differentially expressed circRNAs and mRNAs using qRT-PCR.
  • Bioinformatic analysis including ceRNA network construction, GO, and KEGG pathway analysis.

Main Results:

  • Identification of 9585 circRNAs and 22050 mRNAs.
  • Significant up-regulation of 213 circRNAs and 617 mRNAs in DCM hearts.
  • Significant down-regulation of 85 circRNAs and 1125 mRNAs in DCM hearts.
  • Construction of two circRNA-miRNA-mRNA networks.

Conclusions:

  • Cardiac circRNA expression is significantly altered in human DCM.
  • circRNAs may play a crucial role in DCM development through ceRNA mechanisms.
  • This study provides a foundation for further research into circRNAs as potential therapeutic targets for DCM.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
152
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
199
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
149